Past-Month Cannabis Use Among Adults With Diabetes in the U.S., 2021–2022.

A recent study examined the prevalence of cannabis use among adults with diabetes in the United States. The study found that 9.0% of adults with diabetes reported using cannabis in the past month, with an increase from 7.7% in 2021 to 10.3% in 2022. Factors associated with cannabis use among adults with diabetes included residing in states where cannabis is legal, a history of hepatitis, past-year major depressive episode, past-year emergency department use, past-month tobacco use, binge drinking, opioid misuse, and stimulant misuse. The study emphasizes the need for further research on the effects of cannabis use on the health of patients with diabetes and suggests comprehensive substance use screenings in diabetes care. However, the study acknowledges limitations such as self-reporting and the lack of distinction between types of diabetes and cannabinoid products used. Clinicians are advised to discuss the potential harms of cannabis use with their patients with diabetes. [Extracted from the article]